NCT05622435

Clinical Investigation to Evaluate the Tolerance of T10070 on Healthy Volunteers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 39 (actual)
• Sponsor: Laboratoires Thea · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial investigation is to evaluate the tolerance of the T10070 on healthy volunteers by clinical examination under ophthalmological control. Participants will attend 2 visits (inclusion at day 0 and follow-up/final at D7/D9. After inclusion, subjects will have to apply T10070 6 times a day during 7 to 9 days. The following tasks will be asked to participants: * ophtalmological examination * diary completion to record T10070 applications, potential discomfort/reactions observed and medication taken. * complete subject questionnaire about usability of the product

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DEVICE	T10070, Plastic tube with a roll-on applicator filled with an ointment	6 times per day on both (upper and lower) eyelids of right eye during 7 to 9 days.

Timeline

• Start date: 2022-10-17
• Primary completion: 2022-11-10
• Completion: 2022-11-10
• First posted: 2022-11-18
• Last updated: 2022-12-07

Locations

1 site across 1 country: Poland